These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39096485)

  • 1. Huperzine A suppresses absence seizures in the genetic absence epilepsy rat from Strasbourg (GAERS) model of genetic generalized epilepsy with absence seizures.
    Casillas-Espinosa PM; Garcia-Olivares J; Li R; Li C; Yu C; Formella AE; O'Brien TJ
    Epilepsia Open; 2024 Oct; 9(5):1826-1836. PubMed ID: 39096485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy.
    Dezsi G; Ozturk E; Stanic D; Powell KL; Blumenfeld H; O'Brien TJ; Jones NC
    Epilepsia; 2013 Apr; 54(4):635-43. PubMed ID: 23464801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized cortical injections of ethosuximide suppress spike-and-wave activity and reduce the resistance to kindling in genetic absence epilepsy rats (GAERS).
    Gülhan Aker R; Tezcan K; Carçak N; Sakalli E; Akin D; Onat FY
    Epilepsy Res; 2010 Mar; 89(1):7-16. PubMed ID: 19939632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of chronic treatment with sodium channel blocker lacosamide on early development of absence seizures in genetic absence epilepsy rats.
    Çarçak N; Karanfil C; Akat Ş; Akman Ö; Onat F
    Epilepsy Res; 2022 May; 182():106896. PubMed ID: 35286866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of caffeine and adenosine receptor ligands on the expression of spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg (GAERS).
    Germé K; Faure JB; Koning E; Nehlig A
    Epilepsy Res; 2015 Feb; 110():105-14. PubMed ID: 25616462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-2a adrenergic receptor activation in genetic absence epilepsy: An absence status model?
    Yavuz M; Akkol S; Onat F
    Epilepsia Open; 2024 Apr; 9(2):534-547. PubMed ID: 38071480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of ethosuximide on amino acids in genetic absence epilepsy rat model.
    Terzioğlu B; Aypak C; Onat FY; Küçükibrahimoğlu E; Ozkaynakçi AE; Gören MZ
    J Pharmacol Sci; 2006 Mar; 100(3):227-33. PubMed ID: 16538026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topiramate in two models of genetically determined generalized epilepsy, the GAERS and the Audiogenic Wistar AS.
    Rigoulot MA; Boehrer A; Nehlig A
    Epilepsia; 2003 Jan; 44(1):14-9. PubMed ID: 12581224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spike and wave discharges detection in genetic absence epilepsy rat from Strasbourg and patients with genetic generalized epilepsy.
    Li R; Millist L; Foster E; Yuan X; Guvenc U; Radfar M; Marendy P; Ni W; O'Brien TJ; Casillas-Espinosa PM
    Epilepsy Res; 2023 Aug; 194():107181. PubMed ID: 37364342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal application of ethosuximide is highly efficient in suppressing seizures in a genetic model of absence epilepsy.
    Buschhoff AS; Scherließ R; de Mooij-van Malsen JG; Schiffelholz T; Stephani U; Wulff P
    Epilepsy Res; 2022 Aug; 184():106967. PubMed ID: 35772325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS.
    François J; Boehrer A; Nehlig A
    Epilepsia; 2008 Mar; 49(3):393-9. PubMed ID: 17822432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intracranial administration of ethosuximide in rats with spontaneous or pentylenetetrazol-induced spike-wave discharges.
    Chen SD; Yeh KH; Huang YH; Shaw FZ
    Epilepsia; 2011 Jul; 52(7):1311-8. PubMed ID: 21729038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal administration of neuropeptide Y into the S2 somatosensory cortex maximally suppresses absence seizures in a genetic rat model.
    van Raay L; Jovanovska V; Morris MJ; O'Brien TJ
    Epilepsia; 2012 Mar; 53(3):477-84. PubMed ID: 22220638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the T-type calcium channel Ca
    Casillas-Espinosa PM; Lin R; Li R; Nandakumar NM; Dawson G; Braine EL; Martin B; Powell KL; O'Brien TJ
    Neurobiol Dis; 2023 Aug; 184():106217. PubMed ID: 37391087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD003032. PubMed ID: 33475151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model.
    Russo E; Citraro R; Scicchitano F; De Fazio S; Perrotta I; Di Paola ED; Constanti A; De Sarro G
    Epilepsia; 2011 Jul; 52(7):1341-50. PubMed ID: 21635238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizure expression, behavior, and brain morphology differences in colonies of Genetic Absence Epilepsy Rats from Strasbourg.
    Powell KL; Tang H; Ng C; Guillemain I; Dieuset G; Dezsi G; Çarçak N; Onat F; Martin B; O'Brien TJ; Depaulis A; Jones NC
    Epilepsia; 2014 Dec; 55(12):1959-68. PubMed ID: 25377760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral energy metabolism in rats with genetic absence epilepsy is not correlated with the pharmacological increase or suppression of spike-wave discharges.
    Nehlig A; Vergnes M; Marescaux C; Boyet S
    Brain Res; 1993 Jul; 618(1):1-8. PubMed ID: 8402164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y suppresses absence seizures in a genetic rat model.
    Stroud LM; O'Brien TJ; Jupp B; Wallengren C; Morris MJ
    Brain Res; 2005 Feb; 1033(2):151-6. PubMed ID: 15694919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.